Central nervous system tumors symptoms and treatment
Download from iTunes: https://itunes.apple.com/us... A central nervous system tumor starts as a primary cancer originating in the brain, spi...
Author: mdanderson
Added: 11/18/2013 (Source: Oncology Tube)
Source: Oncology Tube - November 18, 2013 Category: Cancer & Oncology Source Type: podcasts
New Hope for Fighting Lung Cancer that Spreads to the Brain
Lung cancer is especially deadly when the cancer cells spread elsewhere in the body. Treating the metastases in the brain has been difficult because most medicines do not cross "the blood-brain b...
Author: patientpower
Added: 11/07/2013 (Source: Oncology Tube)
Source: Oncology Tube - November 7, 2013 Category: Cancer & Oncology Source Type: podcasts
CH5424802 in brain metastases - Dr. Parneet Cheema
For more updates visit www.oncologyeducation.com....
Video update from the 15th World Conference on Lung Cancer. Consistent therapeutic efficacy of CH5424802 in brain metastases among crizotinib-refra...
Author: oncologyeducation
Added: 11/05/2013 (Source: Oncology Tube)
Source: Oncology Tube - November 5, 2013 Category: Cancer & Oncology Source Type: podcasts
"THE OVERHEAD MYTH": DISRUPTING & DEBUNKING NONPROFITS - Oct 08,2013
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. nonprofit overhead myth | ken berger charity navigator | jacob harold gui...
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
"the overhead myth": disrupting & debunking nonprofits
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
"THE OVERHEAD MYTH": DISRUPTING & DEBUNKING NONPROFITS - okt 08,2013
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
"THE OVERHEAD MYTH": DISRUPTING & DEBUNKING NONPROFITS - Okt 08,2013
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
"the overhead myth": disrupting & debunking nonprofits - 十月 08,2013
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
"the overhead myth": disrupting & debunking nonprofits
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - October 8, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
When cancer spreads to the brain
Download from iTunes: https://itunes.apple.com/us... Several cancer types can spread to the brain including lung, breast, melanoma, renal cel...
Author: mdanderson
Added: 10/07/2013 (Source: Oncology Tube)
Source: Oncology Tube - October 7, 2013 Category: Cancer & Oncology Source Type: podcasts
"THE OVERHEAD MYTH": DISRUPTING & DEBUNKING NONPROFITS - Oct 08,2013
The myth of "overhead" when it comes to donating to charity is finally getting it's comeuppance. It's time to think differently about causes, the public perception of impact and what's being done to turn the industry on it's ear to be more effective and transparent for the 21st century. Join us as we welcome VIPs, Jacob Harold (President/CEO, GuideStar), Ken Berger (President/CEO, Charity Navigator) and Art Taylor (President/CEO BBB Wise Giving Alliance). Survivor spotlight on young adult brain tumor survivor and healthcare blogger Catherine Blotner. nonprofit overhead myth | ken berger charity navigator | jacob harold gui...
Source: The Stupid Cancer Show - Blog Talk Radio - October 4, 2013 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Study offers new insights for bevacizumab use in patients with brain cancer
Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life, and these changes often predict treatment outcom...
Author: mdanderson
Added: 06/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2013 Category: Cancer & Oncology Source Type: podcasts
Recent study on drug for newly diagnosed glioblastoma patients
Download from iTunes: https://itunes.apple.com/us.... Bevacizumab offers no benefit for newly diagnosed glioblastoma (brain) cancer patient...
Author: mdanderson
Added: 06/04/2013 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2013 Category: Cancer & Oncology Source Type: podcasts
ASCO Plenary Session: Not Your Usual Suspects
Dr. Kathy Miller previews the exceptional studies to be presented at the ASCO plenary session, ranging from rare tumors of the brain and thyroid to a screening strategy that has global implications. (Source: Medscape Oncology)
Source: Medscape Oncology - May 23, 2013 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
